JADE HASKINS: Open Payments
NPI 1568172831 · BOWLING GREEN, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$642 in 36 payments from 15 companies in 2025. Trend: 2023 $279 · 2024 $281 · 2025 $642
Food & beverage: $623Education: $19
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 12 | $147 |
| Lilly USA, LLC | 4 | $102 |
| Novo Nordisk Inc | 4 | $97 |
| Amgen Inc. | 3 | $51 |
| GlaxoSmithKline, LLC. | 2 | $37 |
| PFIZER INC. | 2 | $33 |
| Dynavax Technologies Corporation | 1 | $31 |
| Exact Sciences Corporation | 1 | $22 |
| VERTEX PHARMACEUTICALS INCORPORATED | 1 | $20 |
| Abbott Laboratories | 1 | $19 |
Products named: UBRELVY, MOUNJARO, Ozempic, EVENITY, QULIPTA, SHINGRIX, Heplisav-B, ZEPBOUND.
Industry payments across VA — which companies pay providers there.
